Table 5.
Prognostic analysis of factors predicting recurrence-free survival in adjuvant chemotherapy: multivariate analysis according to chemotherapy regimens
| PB chemotherapy
|
Oral-FT chemotherapy
|
|||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | |
| Nodal metastasis | ||||||
| Positive/negative | 35.6 | 4.00–316.4 | 0.001 | 4.93 | 1.23–19.74 | 0.024 |
| PNI before chemotherapy | ||||||
| <50/≥50 | 2.58 | 0.85–7.85 | 0.095 | 5.45 | 1.32–22.39 | 0.019 |
Notes: P-values in bold indicate significance (P<0.05).
Abbreviations: PNI, prognostic nutritional index; PB, platinum-based; HR, hazard ratio; CI, confidence interval; FT, tegafur.